Roula Ghaoui and Merrilee Needham

There is emerging evidence that early TPE in NMSOD relapses results in more favourable outcomes. Although the optimal timing is unclear, there is increasing evidence that early TPE within the first two days may offer the greatest degree of recovery in NMSOD relapses. Given underlying shared immunological mechanisms between NMSOD and other CNS-IDD, there may […]

Sarah Leeder

Simon Broadley, Elham Khalili, Saman Heshmat, Laura Clarke

STADA Australia continues to innovate in Parkinson’s Disease with MOVAPO® pre-filled syringes (PFS) Parkinson’s Disease is a surprisingly prevalent condition with an estimated 10 million people worldwide and roughly 70,000 Australians (1 in every 340 people) suffering from the condition.1 It is the second most prevalent neurological condition exceeded only by dementia. It is more common […]